GeneReach Biotechnology (Taiwan) Widgets and Gadgets
4171 Stock | TWD 24.50 0.30 1.21% |
Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- 4171 GeneReach Biotechnology
- 4171 24.5 -0.3
- Low 23.8
- High 24.8
- Alpha -0.0476
- Beta 0.47
- Return On Equity 0.3
- Return On Asset 0.13
- Profit Margin 0.38 %
- Operating Margin 0.43 %
- Current Valuation 2.09 B
- Shares Outstanding 45.97 M
- Shares Owned By Insiders 34.96 %
- Shares Owned By Institutions 4.57 %
- Price To Earning 8.39 X
- Price To Book 2.37 X
- Price To Sales 2.88 X
- Revenue 1.01 B
- Gross Profit 746.98 M
- EBITDA 535.64 M
- Net Income 376.62 M
- Cash And Equivalents 811.4 M
- Cash Per Share 17.65 X
- Total Debt 217.39 M
- Debt To Equity 0.30 %
- Current Ratio 5.21 X
- Book Value Per Share 24.36 X
- Cash Flow From Operations 348.99 M
- Earnings Per Share 6.90 X
- Number Of Employees 16
- Beta 0.63
- Market Capitalization 2.73 B
- Total Asset 1.68 B
- Z Score 7.2
- Annual Yield 0.08 %
- Net Asset 1.68 B
- Last Dividend Paid 4.55
- Accumulation Distribution 0.0403
- Daily Balance Of Power (0.30)
- Rate Of Daily Change 0.99
- Day Median Price 24.3
- Day Typical Price 24.37
- Market Facilitation Index 1.0
- Price Action Indicator 0.05
- Period Momentum Indicator (0.30)
- Relative Strength Index 34.52
Market Snapshot Widget Example
DAX Index Germany | 22,462 0.96 | |
Taiwan Weighted Taiwan | 21,603 1.59 | |
PSI 20 Stock Portugal | 6,951 0.75 | |
CROBEX Croatia | 3,329 0.11 | |
Budapest SE Hungary | 91,416 1.41 | |
IDX 30 Jakarta Indonesia | 386.86 0.42 | |
ISEQ 20 Price Ireland | 1,760 1.45 | |
NYSE Comp USA | 19,270 1.35 | |
Tel Aviv 35 Israel | 2,461 0.89 | |
Coreshares Index Tracker South Afric | 1,108 1.95 | |
IPC MEXICO Mexico | 53,173 0.57 | |
KL Technology Malaysia | 50.27 1.32 | |
IBEX 35 Index Spain | 13,309 0.84 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 4,176 2.08 | |
SPASX Dividend Opportunities Australia | 1,661 0.80 | |
HNX 30 Vietnam | 502.01 1.15 | |
Bucharest BET-NG Romania | 1,262 0.07 | |
AMS Small Cap Netherlands | 1,381 0.78 | |
Oslo Exchange Mutual Norway | 1,463 1.34 | |
BEL Small Belgium | 8,418 0.15 | |
Basic Materials Brazil | 5,422 1.55 | |
Swiss Leader Price Switzerland | 2,074 0.42 | |
Fondo Mutuo ETF Chile | 1,563 0.48 | |
Athens General Comp Greece | 1,736 0.6 | |
Stock Exchange Of Thailand | 1,175 1.05 | |
PX Prague Stock Czech Repub | 2,119 1.22 | |
THE PHILIPPINE STOCK Philippines | 6,147 0.13 | |
WIG 30 Poland | 3,505 1.04 | |
BIST Electricity Turkey | 465.96 1.39 |
Investing Ideas
In addition to having GeneReach Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare GeneReach Biotechnology
Compare GeneReach Biotechnology To Peers
Additional Tools for GeneReach Stock Analysis
When running GeneReach Biotechnology's price analysis, check to measure GeneReach Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneReach Biotechnology is operating at the current time. Most of GeneReach Biotechnology's value examination focuses on studying past and present price action to predict the probability of GeneReach Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneReach Biotechnology's price. Additionally, you may evaluate how the addition of GeneReach Biotechnology to your portfolios can decrease your overall portfolio volatility.